Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002026368> ?p ?o ?g. }
- W2002026368 endingPage "675" @default.
- W2002026368 startingPage "667" @default.
- W2002026368 abstract "Introduction and ObjectivesPatients with either renovascular hypertension (RVH) and/or renal insufficiency (RI) due to renal artery ostial occlusive disease (RAOOD) can successfully undergo an open surgical reconstruction procedure (OSRP), but since the publication of Blum et al1Blum U. Krumme B. Fluegel P. Gabelmann A. Lehnert T. Buitrago-Tellez C. et al.Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty.N Engl J Med. 1997; 336: 459-465Crossref PubMed Scopus (521) Google Scholar percutaneous balloon stent angioplasty (PTRA + stent) leaving a small part of the stent within the aorta has become very popular. However, balloon dilatation and stenting does not remove the atherosclerotic plaque, which is often heavily calcified but leads to disruption of the plaque causing myointimal hyperplasia and recurrent stenosis. Therefore, a comparison of the two treatment modalities concerning complications and durability in a prospective randomized design was felt to bring more insight to the discussion.MethodsFrom 1998 to 2004, we performed OSRP in 330 patients with RVH and/or RI for various locations of RAOOD. During this time period, 50 patients (female 18, male 32, mean age 64.4 years) with RAOOD of at least 70% stenosis (DSA and duplex criteria) in one or both renal arteries, who did not require other aorto/mesenteric/iliac reconstructive procedures agreed and were randomized to either OSRP (n = 25 patients, 49 arteries) or PTRA + stent (n = 25 patients, 28 arteries). Two patients crossed over to surgical treatment. Patients were followed on a regular basis for 4 years and longer. Endpoints were re-occurrence of RAOOD and impairment of either kidney function or RVH.ResultsWe approached 77 arteries. There was no early mortality in either group, but directly procedure-related morbidity was 13% in the interventional group and 4% in the surgical group. Four-year follow-up mortality was 18% in the interventional group and 25% in the surgical group. Both groups showed significant improvement of RVH (P < .001 in each group) as well as improvement or stabilization in patients with insufficient renal function. Freedom from recurrent RAOOD (>70%) was achieved in 90.1% of the surgical group and 79.9% of the interventional group.ConclusionBoth treatment modalities showed good early results concerning RVH, kidney function, and renal perfusion. Despite a higher number of bilateral renal artery reconstructions in patients undergoing OSRP, which was probably due to the preferred technique of transaortic endarterectomy eliminating the plaque originating in the aorta and usually extending into both renal arteries, mortality was not higher and procedure-related morbidity was even lower compared to PTRA + stent. These findings and also longer durability of OSRP imply that surgical reconstruction remains the gold standard for patients with RAOOD before PTRA + stent may be considered." @default.
- W2002026368 created "2016-06-24" @default.
- W2002026368 creator A5000821007 @default.
- W2002026368 creator A5009894763 @default.
- W2002026368 creator A5016541523 @default.
- W2002026368 creator A5059574559 @default.
- W2002026368 creator A5074813803 @default.
- W2002026368 creator A5075371315 @default.
- W2002026368 creator A5089157608 @default.
- W2002026368 date "2009-03-01" @default.
- W2002026368 modified "2023-10-15" @default.
- W2002026368 title "Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD)" @default.
- W2002026368 cites W2004695874 @default.
- W2002026368 cites W2007813551 @default.
- W2002026368 cites W2008663704 @default.
- W2002026368 cites W2009205042 @default.
- W2002026368 cites W2011668656 @default.
- W2002026368 cites W2023406248 @default.
- W2002026368 cites W2034579939 @default.
- W2002026368 cites W2037989593 @default.
- W2002026368 cites W2050508800 @default.
- W2002026368 cites W2063240993 @default.
- W2002026368 cites W2067284023 @default.
- W2002026368 cites W2085857295 @default.
- W2002026368 cites W2089659728 @default.
- W2002026368 cites W2131831286 @default.
- W2002026368 cites W2140029164 @default.
- W2002026368 cites W2160627300 @default.
- W2002026368 cites W2162187836 @default.
- W2002026368 cites W2339016240 @default.
- W2002026368 cites W2411345955 @default.
- W2002026368 cites W4247555566 @default.
- W2002026368 cites W428223256 @default.
- W2002026368 cites W4317929373 @default.
- W2002026368 doi "https://doi.org/10.1016/j.jvs.2008.10.006" @default.
- W2002026368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19135837" @default.
- W2002026368 hasPublicationYear "2009" @default.
- W2002026368 type Work @default.
- W2002026368 sameAs 2002026368 @default.
- W2002026368 citedByCount "65" @default.
- W2002026368 countsByYear W20020263682012 @default.
- W2002026368 countsByYear W20020263682013 @default.
- W2002026368 countsByYear W20020263682014 @default.
- W2002026368 countsByYear W20020263682015 @default.
- W2002026368 countsByYear W20020263682016 @default.
- W2002026368 countsByYear W20020263682017 @default.
- W2002026368 countsByYear W20020263682018 @default.
- W2002026368 countsByYear W20020263682019 @default.
- W2002026368 countsByYear W20020263682020 @default.
- W2002026368 countsByYear W20020263682021 @default.
- W2002026368 countsByYear W20020263682022 @default.
- W2002026368 crossrefType "journal-article" @default.
- W2002026368 hasAuthorship W2002026368A5000821007 @default.
- W2002026368 hasAuthorship W2002026368A5009894763 @default.
- W2002026368 hasAuthorship W2002026368A5016541523 @default.
- W2002026368 hasAuthorship W2002026368A5059574559 @default.
- W2002026368 hasAuthorship W2002026368A5074813803 @default.
- W2002026368 hasAuthorship W2002026368A5075371315 @default.
- W2002026368 hasAuthorship W2002026368A5089157608 @default.
- W2002026368 hasBestOaLocation W20020263681 @default.
- W2002026368 hasConcept C126322002 @default.
- W2002026368 hasConcept C126838900 @default.
- W2002026368 hasConcept C139059822 @default.
- W2002026368 hasConcept C141071460 @default.
- W2002026368 hasConcept C168563851 @default.
- W2002026368 hasConcept C2776634560 @default.
- W2002026368 hasConcept C2778583881 @default.
- W2002026368 hasConcept C2778750487 @default.
- W2002026368 hasConcept C2780007028 @default.
- W2002026368 hasConcept C2780091579 @default.
- W2002026368 hasConcept C2780326628 @default.
- W2002026368 hasConcept C2780813298 @default.
- W2002026368 hasConcept C2781016617 @default.
- W2002026368 hasConcept C2781243531 @default.
- W2002026368 hasConcept C2909028682 @default.
- W2002026368 hasConcept C2909549721 @default.
- W2002026368 hasConcept C71924100 @default.
- W2002026368 hasConcept C84393581 @default.
- W2002026368 hasConceptScore W2002026368C126322002 @default.
- W2002026368 hasConceptScore W2002026368C126838900 @default.
- W2002026368 hasConceptScore W2002026368C139059822 @default.
- W2002026368 hasConceptScore W2002026368C141071460 @default.
- W2002026368 hasConceptScore W2002026368C168563851 @default.
- W2002026368 hasConceptScore W2002026368C2776634560 @default.
- W2002026368 hasConceptScore W2002026368C2778583881 @default.
- W2002026368 hasConceptScore W2002026368C2778750487 @default.
- W2002026368 hasConceptScore W2002026368C2780007028 @default.
- W2002026368 hasConceptScore W2002026368C2780091579 @default.
- W2002026368 hasConceptScore W2002026368C2780326628 @default.
- W2002026368 hasConceptScore W2002026368C2780813298 @default.
- W2002026368 hasConceptScore W2002026368C2781016617 @default.
- W2002026368 hasConceptScore W2002026368C2781243531 @default.
- W2002026368 hasConceptScore W2002026368C2909028682 @default.
- W2002026368 hasConceptScore W2002026368C2909549721 @default.
- W2002026368 hasConceptScore W2002026368C71924100 @default.
- W2002026368 hasConceptScore W2002026368C84393581 @default.
- W2002026368 hasIssue "3" @default.
- W2002026368 hasLocation W20020263681 @default.